Angelika Witoslawska

机构：Tampere University of Applied Sciences, Tampere University · ORCID：0000-0003-0733-652X

发表论文 5 篇 · 总被引 12 次 · h-index 1

代表论文

• Ceramide and phosphatidylcholine lipids‐based risk score predicts major cardiovascular outcomes in patients with heart failure (2024 · European Journal of Clinical Investigation · 被引 11)
• Predictive Performance of the Cardiovascular Event Risk Test 2 Risk Score in Hemodialysis Patients with ESKD (2025 · Clinical Journal of the American Society of Nephrology · 被引 1)
• Fish oil supplementation reduces the CERT2 risk score in adults with increased cardiometabolic risk: Findings from the MoKaRi trial (2026 · Journal of clinical lipidology)
• Ceramide–Phospholipid Risk Score Associates With Cardiovascular Events and Is Lowered by Atorvastatin, Simvastatin, and Anti-PCSK9 Treatments (2026 · Journal of Cardiovascular Pharmacology)
• Evaluation of siRNA therapeutic approaches for the regulation of ceramide synthesis (2025 · European Atherosclerosis Journal)